A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type

NCT02549196 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia of Alzheimer's Type

Interventions

DRUG: Donepezil
DRUG: Solifenacin

Sponsor

Chase Pharmaceuticals Corporation, an affiliate of Allergan plc